Published on 20 Dec 2022 on Market Watch
Abiomed Inc. stock underperforms Monday when compared to competitors despite daily gains
Shares of Abiomed Inc. inched 0.08% higher to $381.30 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.90% to 3,817.66 and Dow Jones Industrial Average falling 0.49% to 32,757.54. This was the stock's third consecutive day of gains. Abiomed Inc. closed $0.69 short of its 52-week high ($381.99), which the company reached on November 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Medtronic PLC rose 0.52% to $77.12, Stryker Corp. fell 0.34% to $239.03, and Boston Scientific Corp. fell 0.02% to $45.80. Trading volume (1.4 M) eclipsed its 50-day average volume of 1.3 M.